Science & Pipeline

A Robust Drug Discovery Platform Has Been Established
to Develop Novel, Potent and Safe RNAi Therapeutics

Pipeline

Target Organ
Candidates
Indications
Targets
Candidate Screening
PCC Nomination
IND Enabling
IND
Early Development
Late Development
  • SGB-3403
    Hypercholesterolemia
    PCSK9
    SGB-9768
    Complement Mediated Diseases
    C3
    SGB-3908*
    Hypertension
    AGT
    Undisclosed
    Immunology-related Disease
    Undisclosed
    Undisclosed
    CVM Diseases
    Undisclosed
  • Undisclosed
    Muscle/ Adipose
    Undisclosed
    Undisclosed
    CNS/ PNS
    Undisclosed
    Undisclosed
    Others
    Undisclosed
*SGB-3908: Partnered with Innovent
  • Home
  • Phone
  • Top